Real-time enrollment status for this small cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 7:53 AM UTC
| NCT Number | NCT07155174 |
| Recruiting Status | Recruiting |
| Condition | Small Cell Lung Cancer |
| Phase | PHASE2 |
| Target Enrollment | 180 participants |
| Active Locations | 11 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | August 25, 2026 (4 days ago) |
As of August 29, 2026: Clinical trial NCT07155174 is currently recruiting participants. This phase2 study for small cell lung cancer is actively seeking new participants at 11 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07155174 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07155174 was last updated 4 days ago (August 25, 2026). HelloStudys verifies this status automatically.